Evidence from experiments employing somatostatin receptor 2 (SSRT2) antagonists and SSRT2 knockout mice strongly suggests that GLP-1s inhibitory actions on -cells are indirect and partially mediated through somatostatin-dependent mechanisms (132)
Research shows nausea, vomiting, diarrhea, constipation, bloating, and delayed gastric emptying are among the most frequently reported side effects associated with these medications, occurring in roughly 40-70% of users
PMID: 1313797
Dosing patterns for hormonal phases While the standard prescribing information for GLP-1 medications like semaglutide or tirzepatide does not include official information for customized dosing based on a patients hormonal phases, there is emerging clinical practice and research focusing on personalized dosing strategies, particularly for women experiencing hormonal shifts
1 Youre placed in a small peer support group within the app
Glucagon-like peptide 1 agonist and effects on reward behaviour: a systematic review